TY  - JOUR
AU  - Fueyo-Marcos, Elena
AU  - Lopez-Pernas, Gema
AU  - Fustero-Torre, Coral
AU  - Antón, Marta Elena
AU  - Al-Shahrour, Fatima
AU  - Fernández-Capetillo, Oscar
AU  - Murga, Matilde
PY  - 2023
DO  - 10.18632/aging.204598
UR  - http://hdl.handle.net/20.500.12105/17696
AB  - Antibodies targeting the PD-1 receptor and its ligand PD-L1 have shown impressive responses in some tumors of bad prognosis. We hypothesized that, since immunosuppressive cells might present several immune checkpoints on their surface, the selective...
LA  - eng
PB  - Impact Journals
KW  - Antineoplastic Agents
KW  - Neoplasms
KW  - Mice
KW  - Animals
KW  - B7-H1 Antigen
KW  - Immunotherapy
KW  - T-Lymphocytes, Cytotoxic
KW  - Cell Line, Tumor
KW  - CD8-Positive T-Lymphocytes
KW  - Tumor Microenvironment
TI  - PD-L1ATTAC mice reveal the potential of depleting PD-L1 expressing cells in cancer therapy.
TY  - journal article
ER  -